Notch signaling dysregulation promotes multiple myeloma-associated bone disease
S. Garavelli(University of Milan), Raffaella Chiaramonte(University of Milan), L. Apicella, Katia Todoerti(Fondazione IRCCS Istituto Nazionale dei Tumori), Carl S. Goodyear(University of Glasgow), Katja Thümmler(Institute of Infection and Immunity), M. Colombo(Human Technopole), Antonino Neri(University of Milan), M. Lancellotti(University of Milan), Elisa Lazzari(University of Trieste), Richard Soutar(NHS Greater Glasgow and Clyde), Moeed Akbar(University of Glasgow), Natalia Platonova(University of Milan)
Cited by 1
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma
|British Journal of Haematology|2004|447
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304